with more than 25 years of industry experience, and vice president of clinical R&D Mary Smith, who led the development and approval of United Therapeutics’ neuroblastoma drug Unituxin.
Qarziba was approved in EU after US-based United Therapeutics withdrew its almost identical drug Unituxin (dinutuximab alpha) from Europe, saying that it could only manufacture enough to supply US ...
After hours: March 25 at 7:05:17 PM EDT Loading Chart for UTHR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback